SBI Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173K Sell
1,101
-80
-7% -$12K ﹤0.01% 713
2026
Q1
$180K Sell
1,181
-54
-4% -$8.28K ﹤0.01% 654
2025
Q4
$170K Sell
1,235
-5,078
-80% -$665K ﹤0.01% 681
2025
Q3
$810K Buy
6,313
+5,769
+1,060% +$704K 0.02% 304
2025
Q2
$65.8K Sell
544
-603
-53% -$68K ﹤0.01% 954
2025
Q1
$128K Buy
1,147
+154
+16% +$16.4K ﹤0.01% 666
2024
Q4
$96.6K Buy
+993
New +$106K ﹤0.01% 767

Other funds holding NVS

SBI Securities's NVS Position: Q2 2026 in Review

SBI Securities reduced its Novartis (NVS) stake by 6.8% in Q2 2026, selling an estimated $12K and leaving 1,101 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

SBI Securities first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $810K in Q3 2025. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • SBI Securities held 1,101 shares of Novartis worth $173K as of Q2 2026.
  • SBI Securities sold 80 Novartis shares in Q2 2026, an estimated $12K.
  • Novartis made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #713 holding.
  • SBI Securities first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Novartis position peaked at $810K in Q3 2025.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.